Retatrutide
From$100.00
Retatrutide (LY3437943) is a novel synthetic peptide functioning as a triple hormone receptor agonist, targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor) pathways. In preclinical and clinical research models, this tri-agonist mechanism has been extensively studied for its synergistic effects on metabolic regulation, energy expenditure, and lipid metabolism. Peptides7 sources Retatrutide exclusively through 99 Purity Peptides, ensuring that every batch is independently verified by HPLC and LC-MS prior to release and accompanied by a comprehensive Certificate of Analysis.
Research Use Only. This compound is intended strictly for laboratory research and development purposes. It is explicitly not for human consumption, diagnostic purposes, or veterinary use.
Retatrutide is supplied as a lyophilized powder across various vial sizes (10mg, 20mg, 30mg, 50mg, and 100mg) to accommodate diverse research protocols. Each vial displays a unique batch number tied to its Certificate of Analysis.
Reconstitution should be performed with bacteriostatic or sterile water under standard aseptic technique. The compound is intended strictly for in-vitro laboratory research applications.
Compound FAQs
Retatrutide (LY3437943) is a triple hormone receptor agonist peptide that targets GLP-1, GIP, and glucagon receptors. It is widely studied in research contexts for its reported roles in comprehensive metabolic regulation and energy homeostasis.
Retatrutide is studied for its simultaneous activation of three key metabolic receptors: GLP-1, GIP, and GCGR (glucagon receptor). This combined activation is theorized in research models to produce synergistic effects on lipid metabolism and energy expenditure beyond what single or dual agonists achieve.
Retatrutide is available in a wide range of vial sizes including 10mg, 20mg, 30mg, 50mg, and 100mg to accommodate varying concentration requirements in research protocols.
Each batch is rigorously tested by an independent third-party laboratory using HPLC for precise purity quantification and LC-MS for molecular identity confirmation, with results published in a batch-specific COA.
Reconstitute with bacteriostatic or sterile water using standard aseptic technique. Unreconstituted lyophilized vials should be stored refrigerated or frozen away from light. Once reconstituted, solutions should be refrigerated and used according to your protocol's specific stability requirements.
No. Retatrutide is classified as a Research Use Only (RUO) laboratory compound. It is strictly intended for in-vitro testing and preclinical research, and is not for human consumption or self-administration.